These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 17386021)

  • 21. A novel pathway of antigen presentation by dendritic and endothelial cells: Implications for allorecognition and infectious diseases.
    Smyth LA; Herrera OB; Golshayan D; Lombardi G; Lechler RI
    Transplantation; 2006 Jul; 82(1 Suppl):S15-8. PubMed ID: 16829787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-priming of CD8+ T cells by viral and tumor antigens is a robust phenomenon.
    Chen W; Masterman KA; Basta S; Haeryfar SM; Dimopoulos N; Knowles B; Bennink JR; Yewdell JW
    Eur J Immunol; 2004 Jan; 34(1):194-9. PubMed ID: 14971045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD8+ T-cell priming regulated by cytokines of the innate immune system.
    Stäger S; Kaye PM
    Trends Mol Med; 2004 Aug; 10(8):366-71. PubMed ID: 15310456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-presentation in viral immunity and self-tolerance.
    Heath WR; Carbone FR
    Nat Rev Immunol; 2001 Nov; 1(2):126-34. PubMed ID: 11905820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
    Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocytosis mechanisms and the cell biology of antigen presentation.
    Burgdorf S; Kurts C
    Curr Opin Immunol; 2008 Feb; 20(1):89-95. PubMed ID: 18249105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracellular mechanisms of antigen cross presentation in dendritic cells.
    Amigorena S; Savina A
    Curr Opin Immunol; 2010 Feb; 22(1):109-17. PubMed ID: 20171863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of mRNA translation in direct MHC class I antigen presentation.
    Apcher S; Manoury B; Fåhraeus R
    Curr Opin Immunol; 2012 Feb; 24(1):71-6. PubMed ID: 22341517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunology. Nothing 'gainst time's scythe can make defense..
    Ploegh HL
    Science; 2004 May; 304(5675):1262-3. PubMed ID: 15166355
    [No Abstract]   [Full Text] [Related]  

  • 30. Cross-priming of cytotoxic T cells dictates antigen requisites for modified vaccinia virus Ankara vector vaccines.
    Gasteiger G; Kastenmuller W; Ljapoci R; Sutter G; Drexler I
    J Virol; 2007 Nov; 81(21):11925-36. PubMed ID: 17699574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outside looking in: the inner workings of the cross-presentation pathway within dendritic cells.
    Villadangos JA; Heath WR; Carbone FR
    Trends Immunol; 2007 Feb; 28(2):45-7. PubMed ID: 17197240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular protein is the source of cross-priming antigen in vivo.
    Shen L; Rock KL
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3035-40. PubMed ID: 14978273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficiency of peptide presentation by dendritic cells compared with other cell types: implications for cross-priming.
    Zehn D; Cohen CJ; Reiter Y; Walden P
    Int Immunol; 2006 Dec; 18(12):1647-54. PubMed ID: 17035346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens.
    Heath WR; Belz GT; Behrens GM; Smith CM; Forehan SP; Parish IA; Davey GM; Wilson NS; Carbone FR; Villadangos JA
    Immunol Rev; 2004 Jun; 199():9-26. PubMed ID: 15233723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The good fat: a link between lipid bodies and antigen cross-presentation.
    Desjardins M
    Immunity; 2009 Aug; 31(2):176-8. PubMed ID: 19699167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chloroquine enhances human CD8+ T cell responses against soluble antigens in vivo.
    Accapezzato D; Visco V; Francavilla V; Molette C; Donato T; Paroli M; Mondelli MU; Doria M; Torrisi MR; Barnaba V
    J Exp Med; 2005 Sep; 202(6):817-28. PubMed ID: 16157687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
    Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY
    Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Traffic of proteins and peptides across membranes for immunosurveillance by CD8(+) T lymphocytes: a topological challenge.
    Johnstone C; Del Val M
    Traffic; 2007 Nov; 8(11):1486-94. PubMed ID: 17822406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-presentation of phage particle antigen in MHC class II and endoplasmic reticulum marker-positive compartments.
    Wan Y; Wu Y; Zhou J; Zou L; Liang Y; Zhao J; Jia Z; Engberg J; Bian J; Zhou W
    Eur J Immunol; 2005 Jul; 35(7):2041-50. PubMed ID: 15940671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of Antigen Export to the Cytosol During Cross-Presentation.
    Gros M; Amigorena S
    Front Immunol; 2019; 10():41. PubMed ID: 30745902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.